Shortage Avoided

ENSPRYNG

HOFFMANN-LA ROCHE LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of ENSPRYNG in Canada?

Not currently. The most recent shortage report for ENSPRYNG 120MG is marked resolved (last updated May 14, 2024).

Can I still get this?Check with your pharmacist

StatusShortage Avoided

Same-ingredient products on fileNone found

Affected strength120MG

Last updated2024-05-14

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02499681

Strength

120MG

Dosage Form

SOLUTION

Route

SUBCUTANEOUS

Active Ingredient

SATRALIZUMAB

Tier

Unrated

Last Updated

2024-05-14

Reason for Shortage

Requirements related to complying with good manufacturing practices.

Source

View original report on healthproductshortages.ca ↗

Other Products from HOFFMANN-LA ROCHE LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

162MG · DIN 02424770

162MG · DIN 02483327

200MG · DIN 02350106

400MG · DIN 02350114

80MG · DIN 02350092

DIN 02147440